Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Charge-conversion chemistry improves hair-rebonding by enhancing penetration and strength.

KY19382 helps regrow hair and create new hair follicles.

The KRTAP15-1 gene affects cashmere fiber thickness in goats.

AKR1B10 enzyme may cause keloid scars and could be a treatment target.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

AgK114 protein helps in hamster skin injury recovery.

A new method can quickly and accurately detect drugs in hair.

Natural α-hydroxyl acids cause skin exfoliation by activating TRPV3 channels.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Estetrol may help prevent hair loss and support hair growth in women.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

Keratin-associated proteins help link filaments and affect keratin's strength.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Scientists discovered a unique hair protein, KAP24.1, with a special structure, found only in the upper part of hair cuticles.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.